| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 02/21/2006 | CA2091181C Cloning of chicken anaemia dna |
| 02/21/2006 | CA2032381C Viral agent |
| 02/19/2006 | CA2512599A1 A method to reduce false positive results |
| 02/17/2006 | CA2478138A1 Cxcl10-based diagnosis and treatment of respiratory illnesses |
| 02/16/2006 | WO2006017859A2 Assays and methods using biomarkers |
| 02/16/2006 | WO2006017821A2 Method for detecting a plurality of different species |
| 02/16/2006 | WO2006017813A2 Methods and compositions for detecting steroids |
| 02/16/2006 | WO2006017812A1 Method for measuring dynamics of self-assembling systems of biological molecules in vivo and uses for discovering or evaluating therapeutic agents |
| 02/16/2006 | WO2006017748A2 Materials and methods for identifying anti-schizophrenic agents |
| 02/16/2006 | WO2006017715A2 Methods of determining immunoresistance to botulinum toxin a |
| 02/16/2006 | WO2006017573A2 Method for the early detection of pancreatic cancer and other gastrointestinal disease conditions |
| 02/16/2006 | WO2006017549A2 Cell-based kinase assay |
| 02/16/2006 | WO2006017473A2 Automated analysis of multiplexed probe-traget interaction patterns: pattern matching and allele identification |
| 02/16/2006 | WO2006017428A2 Use of magnetic material to direct isolation of compounds and fractionation of multipart samples |
| 02/16/2006 | WO2006017208A1 Mass tags for quantitative analyses |
| 02/16/2006 | WO2006017196A1 Stable cyanine dye phosphoramidites |
| 02/16/2006 | WO2006017181A2 Methods and systems for predicting protein-ligand coupling specificities |
| 02/16/2006 | WO2006017140A2 Methods for optically encoding an object with upconverting materials and compositions used therein |
| 02/16/2006 | WO2006016697A1 Non-small cell lung cancer-related gene, anln, and its interactions with rhoa |
| 02/16/2006 | WO2006016696A1 Interaction of colon cancer related gene c20orf20 with p120 |
| 02/16/2006 | WO2006016692A1 Knockout nonhuman animal |
| 02/16/2006 | WO2006016644A1 Antibody and utilization of the same |
| 02/16/2006 | WO2006016597A1 Method of evaluating physical conditions using head hair or body hair |
| 02/16/2006 | WO2006016525A2 Genes and polypeptides relating to breast cancers |
| 02/16/2006 | WO2006016235A1 Method to evaluate the instability of proteins contained in an acid ph drink |
| 02/16/2006 | WO2006016188A1 Gas sensor |
| 02/16/2006 | WO2006016121A1 Thyrotropin receptor preparations, binding regions thereof, antibody and hormone interactions therewith, and uses thereof |
| 02/16/2006 | WO2006016113A1 Cellular tcr ligand assay method |
| 02/16/2006 | WO2006016063A1 Novel glycopolymers, uses thereof, and monomers useful for preparation thereof |
| 02/16/2006 | WO2006016051A2 Device with removal member for detecting an analyte in a liquid sample |
| 02/16/2006 | WO2006016044A1 Novel microfluidic system and method for capturing cells |
| 02/16/2006 | WO2006015976A1 Diagnostic and therapeutic use of a plasma membrane atpase |
| 02/16/2006 | WO2006015962A1 Method of printing a time-temperature indicator based on azo coupling reactions onto a substrate |
| 02/16/2006 | WO2006015874A2 Method for diagnosing liver fibrosis |
| 02/16/2006 | WO2006015463A2 Soil survey device |
| 02/16/2006 | WO2006000813A3 Testing kit |
| 02/16/2006 | WO2005124359A3 Methods of diagnosing and treating diabetes and insulin resistance |
| 02/16/2006 | WO2005121800A3 Improvements in or relating to lateral flow assay devices |
| 02/16/2006 | WO2005121366A8 Gene marker and utilization of the same |
| 02/16/2006 | WO2005119263A3 Diagnostics and therapeutics for diseases associated with g protein-coupled receptor 92 (gpr92) |
| 02/16/2006 | WO2005116622B1 Connector configuration for electrochemical cells and meters for use in combination therewith |
| 02/16/2006 | WO2005115433A3 Methods for cyclizing synthetic polymers |
| 02/16/2006 | WO2005114218A3 Cross-screening system and methods for detecting a molecule having binding affinity for a target molecule |
| 02/16/2006 | WO2005114187A3 Methods and compositions for diagnosing aids and other diseases and conditions involving immune system activation |
| 02/16/2006 | WO2005113814A3 Biomarkers of chronic pelvic pain syndrome |
| 02/16/2006 | WO2005106036A3 Methods and compositions for assaying analytes |
| 02/16/2006 | WO2005105064A3 Modulators of frat-lrp interaction in the treatment of bone-related diseases |
| 02/16/2006 | WO2005103702A3 Diagnostics and therapeutics for diseases associated with cxc chemokine receptor 2 (cxcr2) |
| 02/16/2006 | WO2005103680A3 Method and device for increasing the selectivity of fet-based gas sensors |
| 02/16/2006 | WO2005090948A3 Composite organic-inorganic nanoclusters |
| 02/16/2006 | WO2005076012A3 Novel splice variants and methods of use thereof |
| 02/16/2006 | WO2005072380A3 Membrane attack complexes associated with circulating immune complexes |
| 02/16/2006 | WO2005066633A3 Fluorescent ligands for gpcr arrays |
| 02/16/2006 | WO2005062770A3 Method for conducting pharmacogenomics-based studies |
| 02/16/2006 | WO2005050224A3 Small molecule and peptide arrays and uses thereof |
| 02/16/2006 | WO2005050157A3 Electrochemical method and sensor for the detection of trace explosives |
| 02/16/2006 | WO2005047509A8 The mycolactone locus : an assembly line for producing novel polyketides, with therapeutic and prophylatic uses |
| 02/16/2006 | WO2005039573A3 Biomarkers for the prediction of drug-induced diarrhoea |
| 02/16/2006 | WO2005038463A8 Method for the detection of a neurological or psychiatric, demential disease, especially alzheimer's disease by use of cholecystokinin (cck) -molecules, corresponding substances and detection reagents |
| 02/16/2006 | WO2005037056A3 Method for the detection of a biomolecule in a test sample |
| 02/16/2006 | WO2005032455A8 Combinatorially selected phosphorodithioate aptamer targeting ap-1 |
| 02/16/2006 | WO2005032329A3 Methods and compositions for identifying anti-hcv agents |
| 02/16/2006 | WO2005029030A3 Micro scale flow through sorbent plate collection device |
| 02/16/2006 | WO2005011748A3 Method and device for deactivating items and for maintaining such items in a deactivated state |
| 02/16/2006 | WO2005001424A3 Systems and methods for molecular recognition |
| 02/16/2006 | WO2004091510A3 Recombinant il-9 antibodies and uses thereof |
| 02/16/2006 | WO2004091491A3 Profiling conformational variants, antibody compositions and methods of using the same |
| 02/16/2006 | WO2004082796A3 Systems and methods of blood-based therapies having a microfluidic membraneless exchange device |
| 02/16/2006 | WO2004063701A3 Methods of diagnosing and treating cancer |
| 02/16/2006 | WO2004048549A3 Dep-1 receptor protein tyrosine phosphatase interacting proteins and related methods |
| 02/16/2006 | WO2004037986A3 Map2k6 as modifier of branching morphogenensis and methods of use |
| 02/16/2006 | WO2004035805A3 Differential patterns of gene expression that predict for docetaxel chemosensitivity and chemoresistance |
| 02/16/2006 | WO2003086285A3 Live cell method for observing cellular processes |
| 02/16/2006 | WO2003083058A3 Replikin peptides in rapid replication of glioma cells and in influenza epidemics |
| 02/16/2006 | WO2003050293A3 hGC-1, A GENE ENCODING A MEMBER OF THE OLFACTOMEDIN-RELATED PROTEIN FAMILY |
| 02/16/2006 | WO2003025129A3 Neurotransmission-associated proteins |
| 02/16/2006 | WO2002097394A3 Rhesus monkey, dog and ferret melanin-concentrating hormone type 2 receptor |
| 02/16/2006 | US20060036420 Three-dimensional model of a complex between a Fc epsilon receptor alpha chain and a Fc region of an IgE antibody and uses thereof |
| 02/16/2006 | US20060036374 Method for determining three-dimensional protein structure from primary protein sequence |
| 02/16/2006 | US20060036373 Method and system for cropping an image of a multi-pack of microarrays |
| 02/16/2006 | US20060036371 Method for predicting protein-protein interactions in entire proteomes |
| 02/16/2006 | US20060036370 Process, system and method for improving the determination of digestive effects upon an ingestable substance |
| 02/16/2006 | US20060036206 Instrument for collecting and recovering saliva |
| 02/16/2006 | US20060036089 33 human secreted proteins |
| 02/16/2006 | US20060036086 Use of signal transduction inhibitors and combination therapies for the prevention or treatment of cancer and angiogenesis related diseases |
| 02/16/2006 | US20060036079 Surface protein of Leptospira |
| 02/16/2006 | US20060036078 Fluorescent proteins |
| 02/16/2006 | US20060036074 Bromodomain protein |
| 02/16/2006 | US20060035929 Compositions and methods containing substituted quinolines and substituted diphenylsulfones |
| 02/16/2006 | US20060035878 Novel use of ansamycin antibiotics and method of screening novel angiogenesis inhibitor |
| 02/16/2006 | US20060035873 Methods for inducing apolipoprotein e secretion |
| 02/16/2006 | US20060035856 Purified polypeptides having IL-13 receptor activity |
| 02/16/2006 | US20060035855 Purified polypeptides having IL-13 receptor activity |
| 02/16/2006 | US20060035849 Methods and composition for modulating type I muscle formation using pgc-1 alpha |
| 02/16/2006 | US20060035834 Compositions and methods for diagnosing and treating an inflammation |
| 02/16/2006 | US20060035813 Methods and formulations comprising agonists and antagonists of nuclear hormone receptors |
| 02/16/2006 | US20060035389 Immobilization of glycorproteins |
| 02/16/2006 | US20060035388 High-sensitivity magnetic marker used for immune response measurement |
| 02/16/2006 | US20060035387 Non-specific binding resistant protein arrays and methods for making the same |
| 02/16/2006 | US20060035386 Channeled fractionation apparatus for separating, capturing and detecting proteins |